Article Review: FDA Granting Monopoly to a common product

Question

FDA Grants Monopoly Over Preterm Labor Prevention Drug: 15,000 Percent Price Increase Then Announced. https://www.naturalnews.com/031684_FDA_drug_monopoly.html#ixzz1MhG8VURH

Summary

This is a news article review on FDA granting monopoly over preterm labor prevention drug. The article deals with FDA approving KV Pharmaceutical’s drug that prevents preterm labor. The drug itself is a modified version of commonly found progesterone. This move has turned up a lot of attention because of grant of monopoly status for this drug.

Total Word Count 353